Physician profile
Robert K Yarbrough
NPI 1912004540
$2,691.84
in general payments reported to CMS, 2019-2025
11 companies · $218 in 2025
The $218 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,548 · 2020: $145 · 2021: $47.56 · 2022: $303 · 2023: $13.43 · 2024: $418 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $1,659.40 | 2019-2025 | Irrisept |
| Smith+Nephew, INC. | $331.17 | 2021-2024 | Real Intelligence |
| Stryker Corporation | $211.90 | 2019-2021 | |
| Linkbio Corp | $185.69 | 2024 | |
| Medacta USA, INC. | $150.00 | 2022 | |
| Davol INC. | $37.60 | 2025 | |
| Convatec INC. | $29.84 | 2024 | |
| Ermi LLC | $27.74 | 2024 | |
| Carbofix Orthopedics INC | $26.45 | 2025 | |
| Sumitomo Pharma America, INC. | $18.62 | 2025 | Myfembree |
| Conmed Corporation | $13.43 | 2023 | Abc Handpieces |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Yarbrough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.